RecruitingNCT03190837
A Long-term Follow-up Study of Gaucher Disease
Sponsor
Duke University
Enrollment
200 participants
Start Date
Jun 12, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims are to: a) identify the long-term natural history of Gaucher disease, b) evaluate long-term treatment efficacy of enzyme replacement therapy (ERT) and substrate reduction therapy (SRT), and c) identify potential long-term complications of this disorder. These aims will be accomplished through long-term record review of individuals with all three types of Gaucher disease.
Eligibility
Inclusion Criteria1
- Diagnosis of Gaucher Disease
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03190837
Related Trials
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
NCT054875999 locations
Gaucher Disease Outcome Survey (GOS)
NCT032912231 location
World Data on Ambroxol for Patients With GD and GBA Related PD
NCT043889693 locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943318 locations
Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
NCT058435521 location